Chimerix Statistics
Total Valuation
Chimerix has a market cap or net worth of $801.08 million. The enterprise value is $670.62 million.
| Market Cap | 801.08M |
| Enterprise Value | 670.62M |
Important Dates
The last earnings date was Monday, May 5, 2025, before market open.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Chimerix has 93.80 million shares outstanding. The number of shares has increased by 1.24% in one year.
| Current Share Class | 93.80M |
| Shares Outstanding | 93.80M |
| Shares Change (YoY) | +1.24% |
| Shares Change (QoQ) | +0.62% |
| Owned by Insiders (%) | 4.87% |
| Owned by Institutions (%) | 47.37% |
| Float | 80.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3,778.70 |
| Forward PS | n/a |
| PB Ratio | 6.47 |
| P/TBV Ratio | 6.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3,163.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.70, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.70 |
| Quick Ratio | 5.55 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -56.17% and return on invested capital (ROIC) is -38.07%.
| Return on Equity (ROE) | -56.17% |
| Return on Assets (ROA) | -33.64% |
| Return on Invested Capital (ROIC) | -38.07% |
| Return on Capital Employed (ROCE) | -79.06% |
| Revenue Per Employee | $2,684 |
| Profits Per Employee | -$1.12M |
| Employee Count | 79 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +865.63% in the last 52 weeks. The beta is -0.18, so Chimerix's price volatility has been lower than the market average.
| Beta (5Y) | -0.18 |
| 52-Week Price Change | +865.63% |
| 50-Day Moving Average | 7.22 |
| 200-Day Moving Average | 2.98 |
| Relative Strength Index (RSI) | 80.86 |
| Average Volume (20 Days) | 1,813,356 |
Short Selling Information
The latest short interest is 3.39 million, so 3.61% of the outstanding shares have been sold short.
| Short Interest | 3.39M |
| Short Previous Month | 3.41M |
| Short % of Shares Out | 3.61% |
| Short % of Float | 4.21% |
| Short Ratio (days to cover) | 0.42 |
Income Statement
In the last 12 months, Chimerix had revenue of $212,000 and -$88.39 million in losses. Loss per share was -$0.99.
| Revenue | 212,000 |
| Gross Profit | -74.36M |
| Operating Income | -96.57M |
| Pretax Income | -82.59M |
| Net Income | -88.39M |
| EBITDA | -96.47M |
| EBIT | -96.57M |
| Loss Per Share | -$0.99 |
Balance Sheet
The company has $131.64 million in cash and $1.18 million in debt, giving a net cash position of $130.47 million or $1.39 per share.
| Cash & Cash Equivalents | 131.64M |
| Total Debt | 1.18M |
| Net Cash | 130.47M |
| Net Cash Per Share | $1.39 |
| Equity (Book Value) | 121.68M |
| Book Value Per Share | 1.32 |
| Working Capital | 112.08M |
Cash Flow
In the last 12 months, operating cash flow was -$74.98 million and capital expenditures -$287,000, giving a free cash flow of -$75.26 million.
| Operating Cash Flow | -74.98M |
| Capital Expenditures | -287,000 |
| Free Cash Flow | -75.26M |
| FCF Per Share | -$0.80 |
Margins
| Gross Margin | n/a |
| Operating Margin | -45,550.47% |
| Pretax Margin | -41,691.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Chimerix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.24% |
| Shareholder Yield | -1.24% |
| Earnings Yield | -11.03% |
| FCF Yield | -9.40% |
Analyst Forecast
The average price target for Chimerix is $8.51, which is -0.35% lower than the current price. The consensus rating is "Hold".
| Price Target | $8.51 |
| Price Target Difference | -0.35% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 390.35% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Chimerix has an Altman Z-Score of -7.36 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.36 |
| Piotroski F-Score | 2 |